SCRIPPS MEMORIAL HOSPITAL-ENCINITAS
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.7M
- Transactions
- 365
- Companies
- 37
- Average per transaction
- $4,775
Who reported the payments
| Boston Scientific | $357,050 |
| Genentech, Inc. | $349,941 |
| Intercept Pharmaceuticals, Inc. | $320,791 |
| Dexcom, Inc. | $131,459 |
| Novartis | $77,162 |
| Intercept Pharma Europe Ltd. | $74,685 |
| Shockwave Medical, Inc | $70,000 |
| F. Hoffmann-la Roche AG | $36,156 |
| Exelixis Inc. | $35,865 |
| Pharmacyclics LLC, An Abbvie Company | $34,050 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32,407 |
| Biosense Webster, Inc. | $24,750 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $24,500 |
| Genentech USA, Inc. | $19,300 |
| CTI Biopharma Corp. | $18,250 |
| Karyopharm Therapeutics Inc. | $18,000 |
| Medline Industries LP | $15,000 |
| Kyowa Kirin, Inc. | $14,450 |
| Servier Pharmaceuticals LLC | $12,000 |
| Olympus America Inc. | $9,624 |
| CSL Behring | $8,542 |
| Ivantis, Inc | $7,607 |
| Biolinerx USA, Inc. | $7,500 |
| AVEO Pharmaceuticals, Inc. | $7,500 |
| Amgen | $5,800 |
| Xeris Pharmaceuticals, Inc. | $5,000 |
| Cochlear Americas | $4,901 |
| Kls-martin L.p. | $4,360 |
| Tersera Therapeutics LLC | $4,000 |
| Siemens Medical Solutions USA, Inc. | $3,500 |
| Chiesi USA, Inc. | $3,000 |
| Stryker | $2,878 |
| E.r. Squibb & Sons, L.L.C. | $1,600 |
| Fujifilm Sonosite, Inc. | $651 |
| Zimmer Biomet | $275 |
| BD | $142 |
| Sterilmed, Inc. | $97 |